http://rdf.ncbi.nlm.nih.gov/pubchem/reference/4462168

Outgoing Links

Predicate Object
contentType Journal Article
endingPage 277
issn 1432-2072
0033-3158
issueIdentifier 2
pageRange 265-277
publicationName Psychopharmacology
startingPage 265
bibliographicCitation Shoblock JR, Welty N, Nepomuceno D, Lord B, Aluisio L, Fraser I, Motley ST, Sutton SW, Morton K, Galici R, Atack JR, Dvorak L, Swanson DM, Carruthers NI, Dvorak C, Lovenberg TW, Bonaventure P. In vitro and in vivo characterization of JNJ-31020028 (N-(4-{4-[2-(diethylamino)-2-oxo-1-phenylethyl]piperazin-1-yl}-3-fluorophenyl)-2-pyridin-3-ylbenzamide), a selective brain penetrant small molecule antagonist of the neuropeptide Y Y(2) receptor. Psychopharmacology (Berl). 2010 Feb;208(2):265–77. doi: 10.1007/s00213-009-1726-x. PMID: 19953226.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_03dc364b7a4f3a1382bcb44e838812b4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b3180e390af5836e251c1f222f014e44
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1733bd733fccdaebeff3bb458fe04451
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_203e0771712124f92e0a26b92db0ff28
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_55754a785d2b172d4b324d0683e03da1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7cf434578e8e20fbea6d7fb50c7d7fcf
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7c6ac9db839e411378399018613c9e73
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6d11d02125e64f9933e74a95709e8314
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f548e809f069e9244903f6eb4224774f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_53e25756cffdb553444d8b28e688ea5b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d4fe6592124d0444d3a8b197cbf934fc
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c2b7e4a32f519b34e023c14d7832564a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0911b0d27f554b678222f86f3d0ba69c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e5d2691d63481954c283765e60ab0f65
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_38321ce298cc4eed160482af3a7b6b60
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aeb0e9d7d76ec7058e285dc85279cad3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5d92f78b62fa76cb5619d5f4be65fea2
date 2009-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1007/s00213-009-1726-x
https://pubmed.ncbi.nlm.nih.gov/19953226
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/6790
https://portal.issn.org/resource/ISSN/0033-3158
https://portal.issn.org/resource/ISSN/1432-2072
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://scigraph.springernature.com/
https://www.crossref.org/
title In vitro and in vivo characterization of JNJ-31020028 (N-(4-{4-[2-(diethylamino)-2-oxo-1-phenylethyl]piperazin-1-yl}-3-fluorophenyl)-2-pyridin-3-ylbenzamide), a selective brain penetrant small molecule antagonist of the neuropeptide Y Y(2) receptor
discusses http://id.nlm.nih.gov/mesh/M0005217
http://id.nlm.nih.gov/mesh/M0016884
http://id.nlm.nih.gov/mesh/M0014964
http://id.nlm.nih.gov/mesh/M0003153
http://id.nlm.nih.gov/mesh/M0252428
http://id.nlm.nih.gov/mesh/M0543769
http://id.nlm.nih.gov/mesh/M0029538
http://id.nlm.nih.gov/mesh/M0002327
http://id.nlm.nih.gov/mesh/M0026513
http://id.nlm.nih.gov/mesh/M0021771
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_52a428c9d03ea4d36d1dce83fb66583b
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16132350
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460341
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5753
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_93c0e7e698ed879ddb0b0926f376622f
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439260
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25134625
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6923

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128447465
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID66024
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128829306
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129228530
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4887

Total number of triples: 60.